Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease
- PMID: 7887450
- PMCID: PMC1869189
Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease
Abstract
The cellular interactions of advanced glycation end products (AGEs), which have been hypothesized to contribute to the development of vascular lesions, occur, at least in part, through their binding to a novel integral membrane protein, the receptor for AGEs (RAGE). Studies of human vascular segments show that endothelial RAGE expression at the antigen and mRNA level was variable and usually at low levels in samples from healthy individuals. In contrast, patients with a range of peripheral occlusive vascular diseases, with or without underlying diabetes, demonstrated prominent enhancement of endothelial RAGE expression. Smooth muscle cells and nerves in the vessel wall showed constitutively high levels of RAGE expression that were unchanged with aging (from 1 to 92 years) or by the presence of vascular disease. These data suggest that RAGE is likely to have ligands other than AGEs, and that multiple factors in addition to AGEs impact on its expression. Taken together, our findings suggest that RAGE may contribute to the pathogenesis of a range of vascular disorders.
Similar articles
-
Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.Am J Pathol. 1993 Dec;143(6):1699-712. Am J Pathol. 1993. PMID: 8256857 Free PMC article.
-
Expression of receptors for advanced glycation end-products in occlusive vascular and renal disease.Nephrol Dial Transplant. 1996;11 Suppl 5:87-90. doi: 10.1093/ndt/11.supp5.87. Nephrol Dial Transplant. 1996. PMID: 9044315 Review.
-
The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha.J Invest Dermatol. 2006 Feb;126(2):291-9. doi: 10.1038/sj.jid.5700070. J Invest Dermatol. 2006. PMID: 16374460
-
Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells.Kidney Int. 2005 Dec;68(6):2756-65. doi: 10.1111/j.1523-1755.2005.00746.x. Kidney Int. 2005. PMID: 16316350
-
[Receptors for advanced glycation end products and their physiological and clinical significance].Postepy Hig Med Dosw (Online). 2008 Oct 10;62:511-23. Postepy Hig Med Dosw (Online). 2008. PMID: 18936727 Review. Polish.
Cited by
-
The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD.J Clin Med. 2023 May 9;12(10):3366. doi: 10.3390/jcm12103366. J Clin Med. 2023. PMID: 37240472 Free PMC article. Review.
-
Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?Nutrients. 2022 Jun 28;14(13):2675. doi: 10.3390/nu14132675. Nutrients. 2022. PMID: 35807857 Free PMC article. Review.
-
Molecularly targeted nanoparticles: an emerging tool for evaluation of expression of the receptor for advanced glycation end products in a murine model of peripheral artery disease.Cell Mol Biol Lett. 2021 Mar 16;26(1):10. doi: 10.1186/s11658-021-00253-0. Cell Mol Biol Lett. 2021. PMID: 33726678 Free PMC article.
-
Novel Receptor for Advanced Glycation End Products-Blocking Antibody to Treat Diabetic Peripheral Artery Disease.J Am Heart Assoc. 2021 Jan 5;10(1):e016696. doi: 10.1161/JAHA.120.016696. Epub 2020 Dec 17. J Am Heart Assoc. 2021. PMID: 33327730 Free PMC article.
-
AGE-RAGE Axis in the Pathophysiology of Chronic Lower Limb Ischemia and a Novel Strategy for Its Treatment.Int J Angiol. 2020 Sep;29(3):156-167. doi: 10.1055/s-0040-1710045. Epub 2020 May 14. Int J Angiol. 2020. PMID: 33041612 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical